Aurobindo Pharma Limited (NSE:AUROPHARMA)
India
· Delayed Price · Currency is INR 1,171.60
+38.20 (3.37%)
Apr 17, 2025, 3:29 PM IST
Aurobindo Pharma Employees
Aurobindo Pharma had 26,015 employees as of March 31, 2024. The number of employees increased by 2,564 or 10.93% compared to the previous year.
Employees
26,015
Change (1Y)
2,564
Growth (1Y)
10.93%
Revenue / Employee
11.89M INR
Profits / Employee
1.34M INR
Market Cap
680.47B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Apollo Hospitals Enterprise | 83,147 |
| Mankind Pharma | 19,540 |
| Zydus Lifesciences | 26,921 |
| Alkem Laboratories | 17,432 |
| Fortis Healthcare | 12,088 |
Aurobindo Pharma News
- 3 days ago - Aurobindo Pharma gains over 2.5% after USFDA nod for Rivaroxaban tablets in $8.5 billion US market - Business Upturn
- 3 days ago - Top stocks to watch today, April 15: HDFC Bank, Tata Power, Cyient, IRCON, Vedanta, Aurobindo Pharma and more - Business Upturn
- 3 days ago - Stocks to watch today: Zydus, Aurobindo, HCL Tech, Tata Power, Indian Hotels, Cyient in focus on expansion and global deals - Business Upturn
- 6 days ago - Aurobindo Pharma subsidiary receives 11 USFDA observations after North Carolina facility inspection - Business Upturn
- 7 days ago - Aurobindo Pharma shares surge over 3% as subsidiary CuraTeQ Biologics reports successful trial results for bone drug BP16 - Business Upturn
- 7 days ago - Top stocks to watch today, April 11: Tata Steel, Infosys, TCS, BHEL, Aurobindo Pharma, Biocon and more - Business Upturn
- 9 days ago - Pharma Stocks Falls: Aurobindo Pharma slips 2%, Lupin down 2%, Divi’s Labs falls 3% as Trump reiterates tariffs on pharmaceuticals ‘soon’ - Business Upturn
- 12 days ago - Aurobindo Pharma subsidiary secures EU approval for Dyrupeg, a pegylated filgrastim biosimilar - Business Upturn